vs
Side-by-side financial comparison of Global Medical REIT Inc. (GMRE) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
Global Medical REIT Inc. is the larger business by last-quarter revenue ($38.4M vs $32.6M, roughly 1.2× RxSight, Inc.). Global Medical REIT Inc. runs the higher net margin — -16.0% vs -28.1%, a 12.1% gap on every dollar of revenue. On growth, Global Medical REIT Inc. posted the faster year-over-year revenue change (9.2% vs -18.9%). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 4.6%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
GMRE vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.4M | $32.6M |
| Net Profit | $-6.1M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | — | -34.8% |
| Net Margin | -16.0% | -28.1% |
| Revenue YoY | 9.2% | -18.9% |
| Net Profit YoY | -309.2% | -54.1% |
| EPS (diluted) | $-0.48 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.4M | $32.6M | ||
| Q3 25 | $37.2M | $30.3M | ||
| Q2 25 | $38.0M | $33.6M | ||
| Q1 25 | $34.6M | $37.9M | ||
| Q4 24 | $35.2M | $40.2M | ||
| Q3 24 | $34.3M | $35.3M | ||
| Q2 24 | $34.2M | $34.9M | ||
| Q1 24 | $35.1M | $29.5M |
| Q4 25 | $-6.1M | $-9.2M | ||
| Q3 25 | $-5.1M | $-9.8M | ||
| Q2 25 | $585.0K | $-11.8M | ||
| Q1 25 | $3.7M | $-8.2M | ||
| Q4 24 | $2.9M | $-5.9M | ||
| Q3 24 | $3.4M | $-6.3M | ||
| Q2 24 | $-2.0M | $-6.1M | ||
| Q1 24 | $2.3M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | — | -34.8% | ||
| Q3 25 | — | -40.1% | ||
| Q2 25 | — | -41.6% | ||
| Q1 25 | — | -28.2% | ||
| Q4 24 | — | -21.5% | ||
| Q3 24 | — | -26.1% | ||
| Q2 24 | — | -23.9% | ||
| Q1 24 | — | -36.2% |
| Q4 25 | -16.0% | -28.1% | ||
| Q3 25 | -13.6% | -32.4% | ||
| Q2 25 | 1.5% | -35.0% | ||
| Q1 25 | 10.8% | -21.6% | ||
| Q4 24 | 8.4% | -14.8% | ||
| Q3 24 | 9.9% | -17.9% | ||
| Q2 24 | -5.7% | -17.4% | ||
| Q1 24 | 6.6% | -30.8% |
| Q4 25 | $-0.48 | $-0.22 | ||
| Q3 25 | $-0.45 | $-0.24 | ||
| Q2 25 | $-0.01 | $-0.29 | ||
| Q1 25 | $0.03 | $-0.20 | ||
| Q4 24 | $-0.04 | $-0.14 | ||
| Q3 24 | $0.14 | $-0.16 | ||
| Q2 24 | $-0.05 | $-0.16 | ||
| Q1 24 | $0.01 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.1M | $228.1M |
| Total DebtLower is stronger | $1.2M | — |
| Stockholders' EquityBook value | $509.8M | $275.7M |
| Total Assets | $1.2B | $311.8M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.1M | $228.1M | ||
| Q3 25 | $7.1M | $227.5M | ||
| Q2 25 | $6.6M | $227.5M | ||
| Q1 25 | $5.4M | $229.3M | ||
| Q4 24 | $6.8M | $237.2M | ||
| Q3 24 | $5.7M | $237.1M | ||
| Q2 24 | $5.0M | $233.3M | ||
| Q1 24 | $1.3M | $125.4M |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $14.2M | — | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $14.7M | — | ||
| Q1 24 | $25.7M | — |
| Q4 25 | $509.8M | $275.7M | ||
| Q3 25 | $485.3M | $276.0M | ||
| Q2 25 | $503.2M | $278.0M | ||
| Q1 25 | $517.4M | $279.3M | ||
| Q4 24 | $534.1M | $281.2M | ||
| Q3 24 | $542.6M | $277.3M | ||
| Q2 24 | $556.4M | $275.2M | ||
| Q1 24 | $575.0M | $163.9M |
| Q4 25 | $1.2B | $311.8M | ||
| Q3 25 | $1.3B | $308.5M | ||
| Q2 25 | $1.3B | $309.0M | ||
| Q1 25 | $1.3B | $313.0M | ||
| Q4 24 | $1.3B | $318.6M | ||
| Q3 24 | $1.2B | $310.5M | ||
| Q2 24 | $1.2B | $305.5M | ||
| Q1 24 | $1.3B | $183.2M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.03× | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.6M | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-2.3M |
| FCF MarginFCF / Revenue | — | -6.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.6M | $-1.1M | ||
| Q3 25 | $17.6M | $-1.2M | ||
| Q2 25 | $22.1M | $-4.4M | ||
| Q1 25 | $12.3M | $-8.8M | ||
| Q4 24 | $70.0M | $-4.3M | ||
| Q3 24 | $16.3M | $650.0K | ||
| Q2 24 | $18.9M | $-4.0M | ||
| Q1 24 | $14.3M | $-9.3M |
| Q4 25 | — | $-2.3M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-9.4M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | — | $-5.5M | ||
| Q1 24 | — | $-11.3M |
| Q4 25 | — | -6.9% | ||
| Q3 25 | — | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | -24.8% | ||
| Q4 24 | — | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -15.9% | ||
| Q1 24 | — | -38.2% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 3.1% | ||
| Q2 24 | — | 4.4% | ||
| Q1 24 | — | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 37.84× | — | ||
| Q1 25 | 3.28× | — | ||
| Q4 24 | 23.83× | — | ||
| Q3 24 | 4.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 6.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GMRE
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
